Table 1.
Summary of survey responses by country.
| Country | National Maternal Immunization Policy Exists | Active AEFI surveillance: Maternal | Active AEFI surveillance: Infant | Passive AEFI surveillance | Passive: ascertains pregnancy status | Registry for unintentional immunization |
|---|---|---|---|---|---|---|
| High-Income13 | ||||||
| Australia | X | X | X | |||
| Canada | X | |||||
| Chile | X | X | ||||
| Czech Republic | X | |||||
| Denmark | X | X | ||||
| Finland | X | X | X | |||
| Germany | X | X | X | |||
| Ireland | X | * | ||||
| Israel | X | X | ||||
| Latvia | X | X | ||||
| Netherlands | X | X | ||||
| Norway | X | X | X | |||
| Oman | X | X | ||||
| Singapore | X | |||||
| Slovenia | X | |||||
| Sweden | X | X | ||||
| Switzerland | X | X | ||||
| United Kingdom | X | X | X | X | X | X |
| United States | X | X | X | X | X | |
| Middle Income13 | ||||||
| Anguilla | X | X | ||||
| Argentina | X | X | X | X | ||
| Brazil | X | X | X | X | ||
| Bulgaria | ||||||
| Cameroon | X | |||||
| China | X | X | X | |||
| Costa Rica | X | X | X | X | ||
| Côte d'Ivoire | X | |||||
| Ghana | X | |||||
| Hungary | X | X | X | |||
| India | X | X | ||||
| Jordan | X | |||||
| Kyrgyzstan | X | |||||
| Mexico | X | X | X | X | X | |
| Montenegro | X | |||||
| Morocco | ||||||
| Pakistan | X | X | ||||
| Philippines | X | X | X | |||
| Saint Vincent and the Grenadines | X | X | X | |||
| Senegal | X | X | ||||
| Serbia | X | X | ||||
| Sudan | X | X | X | X | X | |
| Thailand | X | |||||
| Low-income13 | ||||||
| Burkina Faso | X | X | ||||
| Cambodia | X | X | X | X | ||
| Congo, the Democratic Republic of the | X | X | X | |||
| Gambia | X | |||||
| Mozambique | X | X |
Note. AEFI, adverse event following immunization
*
No national AEFI surveillance system per WHO criteria, but some AEFI are captured in the national monitoring system for serious adverse drug reactions.